3.0

credits

Average Course Rating

Explores both the justice issues that underlie the application of cell and gene engineering to populations that would benefit, and the science behind how these cures are developed and subsequently delivered to a health care system. Includes an overview of the current technologies that have led to curative interventions for sickle cell disease and engineered immune cells for malignancy, the regulatory and financial issues that the drive cost of these advanced therapies, and the social justice issues of equitable access. Encourages students to synthesize these broad concepts and to propose new solutions that impact public health.